GSE255685 provides per-sample processed expression-score files; values are not raw counts.
| Gene | Pathway | Expression (rlog) | vs Cohort | Cohort Median | %ile |
|---|---|---|---|---|---|
| APOE | Lipid Metabolism | 2.17 | bar=donor line=cohort median | 2.02 | 74.4% |
| FOXO3 | Insulin/IGF-1 Signaling | 10.00 | bar=donor line=cohort median | 9.99 | 51.4% |
| CETP | Lipid Metabolism | 5.14 | bar=donor line=cohort median | 5.05 | 65.1% |
| SIRT6 | Sirtuin Family | 8.24 | bar=donor line=cohort median | 8.34 | 27.1% |
| SIRT1 | Sirtuin Family | 9.08 | bar=donor line=cohort median | 8.72 | 98.4% |
| SIRT3 | Sirtuin Family | 7.38 | bar=donor line=cohort median | 7.49 | 32.1% |
| IGF1R | Insulin/IGF-1 Signaling | 10.35 | bar=donor line=cohort median | 10.21 | 67.9% |
| KLOTHO | Anti-aging | 3.06 | bar=donor line=cohort median | 2.51 | 98.4% |
| APOC3 | Lipid Metabolism | -2.11 | bar=donor line=cohort median | -2.11 | 51.1% |
| IL6 | Inflammation | 1.09 | bar=donor line=cohort median | 1.16 | 32.8% |
| TERT | Telomere Maintenance | 1.46 | bar=donor line=cohort median | 1.51 | 40.3% |
| IRS2 | Insulin/IGF-1 Signaling | 9.45 | bar=donor line=cohort median | 9.81 | 17.7% |
| TP53 | Tumor Suppression | 9.10 | bar=donor line=cohort median | 8.92 | 78.7% |
| SHC1 | Signal Transduction | 9.28 | bar=donor line=cohort median | 9.35 | 25.3% |
| ACE | Signal Transduction | 5.05 | bar=donor line=cohort median | 4.64 | 85.5% |
| # | Gene | ID | Type | Expression (Expression score) | Count |
|---|---|---|---|---|---|
| 1 | MT-RNR2 | 17.6 | 0 | ||
| 2 | B2M | 17.0 | 0 | ||
| 3 | EEF1A1 | 16.7 | 0 | ||
| 4 | MT-CO1 | 16.5 | 0 | ||
| 5 | ACTB | 16.4 | 0 | ||
| 6 | MT-RNR1 | 16.0 | 0 | ||
| 7 | HLA-C | 16.0 | 0 | ||
| 8 | HLA-B | 16.0 | 0 | ||
| 9 | HLA-E | 15.7 | 0 | ||
| 10 | MT-ND4 | 15.7 | 0 |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 1 | S100A8 | 14.2 | bar=donor line=cohort median | 14.4 | 14.2 | 53.2% | |
| 2 | S100A9 | 15.4 | bar=donor line=cohort median | 15.8 | 15.5 | 37.1% | |
| 3 | IL1B | 9.4 | bar=donor line=cohort median | 8.8 | 9.3 | 54.7% | |
| 4 | CXCL8 | 11.4 | bar=donor line=cohort median | 12.2 | 11.4 | 48.9% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 5 | MPO | 5.8 | bar=donor line=cohort median | 6.1 | 6.1 | 31.7% | |
| 6 | FCGR3B | 14.9 | bar=donor line=cohort median | 14.7 | 14.7 | 68.3% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 7 | LYZ | 14.3 | bar=donor line=cohort median | 14.3 | 14.3 | 47.8% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 8 | CD3D | 10.2 | bar=donor line=cohort median | 10.6 | 10.4 | 35.3% | |
| 9 | CD3E | 11.9 | bar=donor line=cohort median | 12.1 | 12.0 | 32.4% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 10 | MS4A1 | 11.2 | bar=donor line=cohort median | 10.8 | 10.9 | 83.0% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 11 | NKG7 | 11.2 | bar=donor line=cohort median | 12.2 | 11.7 | 11.3% | |
| 12 | GNLY | 11.8 | bar=donor line=cohort median | 12.4 | 12.1 | 27.4% |
| # | Gene | Type | Expression | vs Cohort | Group Median | Cohort Median | %ile |
|---|---|---|---|---|---|---|---|
| 16 | MT-CO1 | 16.5 | bar=donor line=cohort median | 16.5 | 16.4 | 61.1% | |
| 17 | MT-CO2 | 15.4 | bar=donor line=cohort median | 15.6 | 15.3 | 59.7% | |
| 18 | MT-ND1 | 15.3 | bar=donor line=cohort median | 15.3 | 15.2 | 71.9% |